About Careers Internship MedBlog Contact us

FDA Approves New Larger Capacity Insulin Pump

by Vishnuprasad on January 13, 2015 at 7:32 PM
FDA Approves New Larger Capacity Insulin Pump

Tandem Diabetes Care, a medical device company, on Monday announced that the U.S. Food and Drug Administration (FDA) has granted the clearance to market the t:flex Insulin Pump.

At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States.


"In recognizing that one size does not fit all, the t:flex Pump was developed using Tandem's proprietary technology platform to bring t:slim's benefits to people with greater insulin needs. This first expansion of our product portfolio reflects our ongoing commitment to deliver user-friendly products that address unmet needs in the diabetes community," said Kim Blickenstaff, President and Chief Executive Officer of Tandem Diabetes Care.

People with diabetes require different amounts of insulin based on their level of insulin sensitivity. The t:flex is designed for people who require more than 100 units of U-100 insulin per day. The pump offers people with greater insulin needs the benefits of pump therapy without the frequent reservoir changes required by 200- and 300-unit capacity pumps. It incorporates the same slim design, advanced Micro-Delivery technology, and simple-to-use, touch-screen interface as the t:slim Insulin Pump.

The t:flex is expected to launch in the US in the second quarter of 2015.

Diabetes is a chronic, life-threatening disease that affects more than 29 million people in the United States. More than 3 million people in the United States require daily administration of insulin and are candidates for pump therapy. Around 400,000 Americans with type 1 diabetes use an insulin pump, or approximately 27% of the type 1 diabetes population. In addition, approximately 75,000 Americans with type 2 diabetes use an insulin pump, a small fraction of the type 2 diabetes population.

Recent studies show that insulin pump therapy reduces average blood glucose levels and overall insulin needs in people with type 2 diabetes compared with standard therapy using multiple daily injections (2). According to a research, two-thirds of endocrinologists cited limited capacity as the number one barrier to insulin pump adoption for people with type 2 diabetes who are insulin dependent.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Medical Gadgets

Revolutionary Artificial Nose Offers Precision Food Spoilage Detection
Our artificial olfactory system combines sensing and processing efficiently, mirroring the biological olfactory system's function for energy and space savings.
IIT Delhi Unveils Exoskeleton Device for Paralyzed Stroke Patients
A portable, lightweight, and affordable exoskeleton designed for stroke patients promises expanded accessibility, particularly in areas with limited resources.
Tap on Your Wrist Makes Navigation Easy: Thanks to a Light Wearable Device
A textile-based wearable device that 'taps' a user's wrist with pressurized air, silently guides the person finding their way to their destination.
New Compact Device Rapidly Detects Infection in Wounds
A device controlled through a mobile app, utilizing heat signatures and bacterial fluorescence, helps detect and address infections in wounds.
Preoperative Anxiety Reduction Through Augmented Reality Rehearsals
An Augmented Reality (AR) walkthrough before the surgery may be a useful tool for reducing preoperative anxiety in patients, a new research has revealed.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

FDA Approves New Larger Capacity Insulin Pump Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests